{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:44:41Z","timestamp":1791351881221,"version":"4.3.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"am","delay-in-days":439,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Vascular Surgery"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.semvascsurg.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T05:29:19Z","timestamp":1714282159000},"page":"188-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Overview and comparison of contemporary Society for Vascular Surgery, American Heart Association\/American College of Cardiology, and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication"],"prefix":"10.1053","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-4631","authenticated-orcid":false,"given":"Li Ting","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin W.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0001","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"issue":"9901","key":"10.1053\/j.semvascsurg.2024.04.006_bib0002","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1358863X08089277","article-title":"National health care costs of peripheral arterial disease in the Medicare population","volume":"13","author":"Hirsch","year":"2008","journal-title":"Vas Med"},{"issue":"3 suppl","key":"10.1053\/j.semvascsurg.2024.04.006_bib0004","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1532-5415.1985.tb02853.x","article-title":"Update on some epidemiologic features of intermittent claudication: the Framingham Study","volume":"33","author":"Kannel","year":"1985","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1053\/j.semvascsurg.2024.04.006_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003796","article-title":"Peripheral artery disease prevalence and incidence estimated from both outpatient and inpatient settings among Medicare Fee-for-Service Beneficiaries in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"6","author":"Kalbaugh","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1053\/j.semvascsurg.2024.04.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12872-018-0960-8","article-title":"Critical appraisal of international guidelines for the screening and treatment of asymptomatic peripheral artery disease: a systematic review","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0009","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jvs.2007.02.004","article-title":"A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences","volume":"45","author":"Sigvant","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2261-10-35","article-title":"Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study","volume":"10","author":"Cimminiello","year":"2010","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0012","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11739-011-0511-0","article-title":"The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk","volume":"6","author":"Cimminiello","year":"2011","journal-title":"Intern Emerg Med"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0013","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ije\/20.2.384","article-title":"Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population","volume":"20","author":"Fowkes","year":"1991","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2021.03.031","article-title":"Risk of peripheral artery disease according to race and sex: The Atherosclerosis Risk in Communities (ARIC) study","volume":"324","author":"Hicks","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.CIR.41.5.875","article-title":"Intermittent claudication. Incidence in the Framingham Study","volume":"41","author":"Kannel","year":"1970","journal-title":"Circulation"},{"issue":"suppl S","key":"10.1053\/j.semvascsurg.2024.04.006_bib0016","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0017","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jvs.2018.07.027","article-title":"Medical and lifestyle management of peripheral arterial disease","volume":"68","author":"Parvar","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0018","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.295.5.547","article-title":"Medical treatment of peripheral arterial disease","volume":"295","author":"Hankey","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.semvascsurg.2024.04.006_bib0019","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.jvs.2023.03.298","article-title":"Low-value peripheral vascular interventions are becoming increasingly prevalent in the treatment of claudication","volume":"77","author":"Dun","year":"2023","journal-title":"J Vasc Surg"},{"issue":"11","key":"10.1053\/j.semvascsurg.2024.04.006_bib0020","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor's choice \u2013 European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0022","series-title":"The RAND\/UCLA Appropriateness Method User's Manual","author":"Fitch","year":"2001"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jacc.2018.10.002","volume":"73","author":"Bailey","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2022.04.012","article-title":"Society for Vascular Surgery appropriate use criteria for management of intermittent claudication","volume":"76","author":"Woo","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor's choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2019.02.066","article-title":"Cigarette smoking intensity informs outcomes after open revascularization for peripheral artery disease","volume":"70","author":"Young","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0027","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial","volume":"56","author":"Hennrikus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0028","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0029","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/M15-0171","article-title":"Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force","volume":"163","author":"Patnode","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0030","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0031","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0032","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0033","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacc.2008.10.008","volume":"53","author":"Skyler","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0034","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"9131","key":"10.1053\/j.semvascsurg.2024.04.006_bib0036","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1053\/j.semvascsurg.2024.04.006_bib0037","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0038","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0039","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"S","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0041","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0042","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0043","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome","volume":"24","author":"Jude","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0044","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/eurheartj\/ehaa1022","article-title":"Do SGLT2 inhibitors increase the risk of amputation? Make haste slowly","volume":"42","author":"Vlachopoulos","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hfc.2022.03.001","article-title":"SGLT2 inhibitors and peripheral vascular events: a review of the literature","volume":"18","author":"Marchiori","year":"2022","journal-title":"Heart Fail Clin"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0046","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","article-title":"Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial","volume":"261","author":"Catalano","year":"2007","journal-title":"J Intern Med"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0047","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"issue":"7329","key":"10.1053\/j.semvascsurg.2024.04.006_bib0048","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Baigent","year":"2002","journal-title":"BMJ"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0049","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","volume":"121","author":"Berger","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1053\/j.semvascsurg.2024.04.006_bib0050","article-title":"Cilostazol for intermittent claudication","volume":"2014","author":"Bedenis","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1053\/j.semvascsurg.2024.04.006_bib0051","article-title":"Cilostazol for intermittent claudication","volume":"6","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1053\/j.semvascsurg.2024.04.006_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003748.pub3","article-title":"Cilostazol for peripheral arterial disease","author":"Robless","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0053","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/bjs.8895","article-title":"Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication","volume":"99","author":"Stevens","year":"2012","journal-title":"Br J Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0054","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejvs.2014.04.019","article-title":"Editor's choice \u2013 the effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis","volume":"48","author":"Gommans","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2015.03.009","article-title":"Supervised vs unsupervised exercise for intermittent claudication: a systematic review and meta-analysis","volume":"169","author":"Vemulapalli","year":"2015","journal-title":"Am Heart J"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0057","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40279-014-0261-z","article-title":"Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis","volume":"45","author":"Parmenter","year":"2015","journal-title":"Sports Med"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0058","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jvs.2012.04.046","article-title":"Supervised walking therapy in patients with intermittent claudication","volume":"56","author":"Fakhry","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0059","doi-asserted-by":"crossref","DOI":"10.1177\/1753944720924270","article-title":"Exercise therapy in routine management of peripheral arterial disease and intermittent claudication: a scoping review","volume":"14","author":"Abaraogu","year":"2020","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0060","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jvs.2019.08.238","article-title":"National assessment of availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication","volume":"71","author":"Dua","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0061","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejvs.2012.09.009","article-title":"Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease","volume":"44","author":"Makris","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2021.03.063","article-title":"An updated systematic review and meta-analysis of home-based exercise programs for individuals with intermittent claudication","volume":"74","author":"Pymer","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0063","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bjs.11101","article-title":"Meta-analysis of clinical trials examining the benefit of structured home exercise in patients with peripheral artery disease","volume":"106","author":"Golledge","year":"2019","journal-title":"Br J Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0064","article-title":"Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia","volume":"77","author":"Sorber","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jvs.2023.07.066","article-title":"Revascularization for claudication: changing the natural history of a benign disease!","volume":"79","author":"McCready","year":"2024","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0066","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.10765","article-title":"Risk of major amputation in patients with intermittent claudication undergoing early revascularization","volume":"105","author":"Golledge","year":"2018","journal-title":"Br J Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0067","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1249\/MSS.0000000000002109","article-title":"Effects of lifestyle physical activity on vascular function in asymptomatic peripheral arterial disease","volume":"52","author":"Laslovich","year":"2020","journal-title":"Med Sci Sports Exerc"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0068","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ccd.28947","article-title":"SCAI guidelines on device selection in Aorto-Iliac arterial interventions","volume":"96","author":"Feldman","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0069","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/bjs.9200","article-title":"Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease","volume":"100","author":"Mazari","year":"2013","journal-title":"Br J Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3400\/avd.tasc.15-01000","volume":"8","author":"Jaff","year":"2015","journal-title":"Ann Vasc Dis"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2016.02.064","article-title":"Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease","volume":"64","author":"Mwipatayi","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0072","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejvs.2022.11.008","article-title":"Editor's choice \u2013 two year results of the randomised DISCOVER trial comparing covered versus bare metal stents in the common iliac artery","volume":"65","author":"Bekken","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0073","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1148\/radiol.2382041053","article-title":"Dutch Iliac Stent Trial: long-term results in patients randomized for primary or selective stent placement","volume":"238","author":"Klein","year":"2006","journal-title":"Radiology"},{"issue":"12","key":"10.1053\/j.semvascsurg.2024.04.006_bib0074","article-title":"Angioplasty versus stenting for iliac artery lesions","volume":"2020","author":"Jongsma","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0075","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jcin.2017.05.015","article-title":"Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial","volume":"10","author":"Krankenberg","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0076","article-title":"The GORE VBX FORWARD Clinical Study: A Comparison of the GORE\u00ae VIABAHN\u00ae VBX balloon expandable endoprosthesis to bare metal stenting for patients with complex iliac occlusive disease","author":"Details","year":"2024","journal-title":"ClinicalTrials.gov"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0077","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jvs.2022.03.864","article-title":"National trends and variability of atherectomy use for peripheral vascular interventions from 2010 to 2019","volume":"76","author":"Nfor","year":"2022","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1053\/j.semvascsurg.2024.04.006_bib0078","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006767.pub2","article-title":"Angioplasty versus stenting for superficial femoral artery lesions","author":"Twine","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0079","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/CIRCULATIONAHA.107.715433","article-title":"Overview of new technologies for lower extremity revascularization","volume":"116","author":"Rogers","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.semvascsurg.2024.04.006_bib0080","article-title":"Atherectomy for peripheral arterial disease","author":"Ambler","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0081","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jvs.2020.10.026","article-title":"Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment","volume":"73","author":"Boufi","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0082","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1593401","article-title":"Systematic review and proportional meta-analysis of endarterectomy and endovascular therapy with routine or selective stenting for common femoral artery atherosclerotic disease","volume":"2019","author":"Changal","year":"2019","journal-title":"J Interv Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2006.04.054","article-title":"Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency","volume":"44","author":"Pereira","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0084","article-title":"Graft type for femoro-popliteal bypass surgery","volume":"5","author":"Twine","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0950-821X(05)80235-X","article-title":"Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex","volume":"6","author":"Vroegindeweij","year":"1992","journal-title":"Eur J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0086","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1051-0443(96)70857-6","article-title":"Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial","volume":"7","author":"Tielbeek","year":"1996","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0087","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jvir.2011.05.013","article-title":"Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus SilverHawk atherectomy and adjunctive balloon angioplasty: randomized trial","volume":"22","author":"Shammas","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0088","first-page":"355","article-title":"The COMPLIANCE 360\u00b0 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease","volume":"26","author":"Dattilo","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0089","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.116.025329","article-title":"Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH)","volume":"135","author":"Ott","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1053\/j.semvascsurg.2024.04.006_bib0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0091","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.avsg.2019.06.014","article-title":"Midterm outcome of directional atherectomy combined with drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal arteriosclerosis obliterans","volume":"64","author":"Cai","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2022.08.033","article-title":"Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population","volume":"77","author":"Bose","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0093","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jcin.2021.01.004","article-title":"Use of atherectomy during index peripheral vascular interventions","volume":"14","author":"Hicks","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2019.10.025","article-title":"Recent trends in clinical setting and provider specialty for endovascular peripheral artery disease interventions for the Medicare population","volume":"31","author":"Schramm","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jvs.2020.10.090","article-title":"Intermittent claudication treatment patterns in the commercially insured non-Medicare population","volume":"74","author":"Siracuse","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0096","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1538574418772459","article-title":"High reintervention and amputation rates after outpatient atherectomy for claudication","volume":"52","author":"Mukherjee","year":"2018","journal-title":"Vasc Endovascular Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0097","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0741-5214(93)90343-K","article-title":"Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: results of primary and secondary procedures","volume":"18","author":"Schweiger","year":"1993","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0098","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0741-5214(86)90073-X","article-title":"Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions","volume":"3","author":"Veith","year":"1986","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0099","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","volume":"8","author":"Zeller","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1053\/j.semvascsurg.2024.04.006_bib0101","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011768","article-title":"Sex-based differences in periprocedural complications following lower extremity peripheral vascular intervention","volume":"15","author":"Altin","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0102","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jvs.2010.05.115","article-title":"Gender differences in daily ambulatory activity patterns in patients with intermittent claudication","volume":"52","author":"Gardner","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0103","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/00005768-200211000-00001","article-title":"Sex differences in claudication pain in subjects with peripheral arterial disease","volume":"34","author":"Gardner","year":"2002","journal-title":"Med Sci Sports Exerc"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2261-11-39","article-title":"Differences in presentation of symptoms between women and men with intermittent claudication","volume":"11","author":"Sigvant","year":"2011","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cjca.2018.01.009","article-title":"Women and peripheral arterial disease: a review of sex differences in epidemiology, clinical manifestations, and outcomes","volume":"34","author":"Srivaratharajah","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0106","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/ATVBAHA.123.319399","article-title":"Sex and racial disparities in peripheral artery disease","volume":"43","author":"Divakaran","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0107","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.CIR.0000157733.50479.B9","article-title":"Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"10.1053\/j.semvascsurg.2024.04.006_bib0108","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015451","article-title":"Underuse of cardiovascular medications in individuals with known lower extremity peripheral artery disease: HCHS\/SOL","volume":"9","author":"Hua","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TCRM.S1458","article-title":"Factors affecting therapeutic compliance: a review from the patient's perspective","volume":"4","author":"Lin","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2013.04.018","article-title":"Socioeconomic disparities in use of cardioprotective medications among patients with peripheral artery disease\u2014an analysis of the American College of Cardiology's NCDR PINNACLE Registry\u00ae","volume":"62","author":"Subherwal","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0111","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCULATIONAHA.122.058998","article-title":"Differences in comorbidities explain Black-white disparities in outcomes after femoropopliteal endovascular intervention","volume":"146","author":"Krawisz","year":"2022","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.avsg.2023.04.022","article-title":"Racial disparities in treatment indications and outcomes for limb ischemia","volume":"96","author":"Semaan","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0113","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jvs.2010.03.066","article-title":"Leg strength predicts mortality in men but not in women with peripheral arterial disease","volume":"52","author":"Singh","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0114","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jvs.2017.02.037","article-title":"Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education","volume":"66","author":"McDermott","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIR.0000000000001153","article-title":"Health disparities in peripheral artery disease: a scientific statement from the American Heart Association","volume":"148","author":"Allison","year":"2023","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0116","article-title":"Reprint of: Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia","volume":"77","author":"Sorber","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2019.10.075","article-title":"Race and socioeconomic differences associated with endovascular peripheral vascular interventions for newly diagnosed claudication","volume":"72","author":"Hicks","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2024.04.006_bib0118","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12939-017-0658-z","article-title":"The effect of socioeconomic disadvantage on prescription of guideline-recommended medications for patients with acute coronary syndrome: systematic review and meta-analysis","volume":"16","author":"Hyun","year":"2017","journal-title":"Int J Equity Health"}],"container-title":["Seminars in Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796724000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796724000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:32:55Z","timestamp":1723649575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895796724000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0895796724000267"],"URL":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2024.04.006","relation":{},"ISSN":["0895-7967"],"issn-type":[{"value":"0895-7967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview and comparison of contemporary Society for Vascular Surgery, American Heart Association\/American College of Cardiology, and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication","name":"articletitle","label":"Article Title"},{"value":"Seminars in Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}